Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report released on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Down 0.1 % Shares of PIRS stock opened at $10.48 on Thursday. Pieris Pharmaceuticals has a twelve month low of $10.31 and […]

Related Keywords

Boston ,Massachusetts ,United States ,Recherches Internationales Servier ,Les Laboratoires Servier ,Cm Management ,Pieris Pharmaceuticals Inc ,Pieris Pharmaceuticals Company Profile ,Boston Pharmaceuticals ,Acadian Asset Management ,News Ratings For Pieris Pharmaceuticals Daily ,Pieris Pharmaceuticals ,Pieris Pharmaceuticals Trading Down ,Pfizer Inc ,Free Report ,Pharmaceuticals Trading Down ,Get Free Report ,Asset Management ,Summit Trail Advisors ,Institut De Recherches Internationales Servier ,Pieris Pharmaceuticals Daily ,